Event Type
Disclosure
Mandatory
Variant
8-K
Results of Operations and Financial Condition. On August 7, 2025, Skye Bioscience, Inc. (the “Company” or “Skye”) issued a press release providing a corporate u
Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Press Release, dated August 7, 2025 104 Cover Page Interactive Data File (embedded